High dose recombinant tumour necrosis factor (rTNF ) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancer

Author： Lejeune F.J.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.6, 1995-06, pp. : 1009-1016

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-dose Recombinant Interleukin-2/Verapamil Combination in Advanced Cancer

By Tagliaferri P.   Correale P.   Mottola M.   de Simone G.   Montesarchio V.   Matano E.   Rea A.   Morabito A.   Famiani M.   Ciardiello F.   Tortora G.   Caraglia M.   Barile C.   Palmieri G.   Bianco A.R.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1436-1437

Elsevier

Access to resources Recommend Favorite

Recombinant Tumour Necrosis Factor in the Local Therapy of Malignant Pleural Effusion

By Rauthe G.   Sistermanns J.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 226-231

Elsevier

Access to resources Recommend Favorite

Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer

By Sousa Hugo   Oliveira Sara   Santos Alexandra   Catarino Raquel   Moutinho José   Medeiros Rui  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2561-2564

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor Necrosis Factor (TNF-a) Antibodies in the Treatment of Renal Cell Cancer

By Maisey Nick  

Cancer Investigation, Vol. 25, Iss. 7, 2007-09 ,pp. : 589-593

Informa Healthcare

Access to resources Recommend Favorite

Tumour Necrosis Factor (TNF) Soluble Receptors in Malignant Melanoma: Correlation with Soluble ICAM-1 Levels

By Viac J.   Vincent C.   Palacio S.   Schmitt D.   Claudy A.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 447-449

Elsevier

Access to resources Recommend Favorite